Recommended Treatment for Shigella Infections
For Shigella infections, ciprofloxacin is the first-line treatment for adults (500 mg twice daily for 3-7 days), while azithromycin is preferred for children (10 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days). 1
Treatment Recommendations by Population
Adults
- First-line: Ciprofloxacin 500 mg twice daily for 3-7 days 1
- Alternative options:
Children
- First-line: Azithromycin 10 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days 1
- Alternative option: Ceftriaxone 1
- Note: Fluoroquinolones are not first-line for children due to concerns about arthropathy, though they can be used when necessary 1
- TMP-SMX dosing for children: 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours for 5 days 2
Special Populations
Immunocompromised Patients
- HIV-infected patients may require extended treatment for up to 14 days 1
- Patients with bacteremia may also need extended treatment for up to 14 days 1
Food Handlers and Healthcare Workers
- May require follow-up stool culture to ensure clearance before returning to work 1
Treatment Considerations
Antibiotic Resistance
- Multiresistant strains of Shigella are widespread globally 1
- High rates of resistance to ampicillin and TMP-SMX have been reported 1
- Increasing resistance to fluoroquinolones observed in some regions 1, 3
- Ciprofloxacin remains effective in many regions with resistance rates as low as 2.6-7% across different Shigella species 3
Treatment Failure
- If no clinical response occurs within 2 days, change to another recommended antibiotic 1
- If no improvement after an additional 2 days, refer for stool microscopy 1
Practical Treatment Algorithm
- Identify patient age and risk factors
- For adults:
- Start ciprofloxacin 500 mg twice daily for 3-7 days
- If contraindicated or unavailable, use azithromycin or TMP-SMX
- For children:
- Start azithromycin 10 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days
- If contraindicated or unavailable, consider ceftriaxone
- Monitor response:
- Assess for clinical improvement within 48 hours
- If no improvement, switch to alternative antibiotic
- Special considerations:
- Extend treatment duration for immunocompromised patients or those with bacteremia
- Consider local resistance patterns when selecting empiric therapy
Important Caveats
- Mass prophylaxis or prophylaxis of family members is not recommended 1
- Local susceptibility patterns should guide therapy choice, particularly for empiric treatment 1
- Antibiotics should be avoided for STEC O157 and other Shiga toxin 2-producing E. coli infections, as antimicrobial therapy may increase the risk of hemolytic uremic syndrome (HUS) 1
- Despite concerns about arthropathy with fluoroquinolones in children, studies have shown ciprofloxacin to be safe and effective in pediatric shigellosis when necessary 4